CTRI/2023/06/054147
Not Yet Recruiting
Phase 3
A randomized, double blind study to evaluate the effect of integrative approach of allopathic and Ayurvedic medications in the management of chronic stable angina
Shathyu Ayurveda Pvt Ltd0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: I998- Other disorder of circulatory system
- Sponsor
- Shathyu Ayurveda Pvt Ltd
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients with symptoms of angina and documented CAD by CTCA with or without prior evidence of CAD will be eligible to be enrolled into the study.
Exclusion Criteria
- •Patients already listed or planning to undergo coronary angioplasty in the 6 month study period
- •Pregnant women
- •Seriously ill patients
- •Patients with psychiatric illnesses
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 2
To see the effect of H-009 and Arsenic-sulphuricum-flavum in color change of vitiligo white patches and examining safety in patientsCTRI/2012/03/002531Homeopathy India Private Limited
Completed
Phase 3
A randomized, double-blind study to evaluate the safety and effectiveness of the Exhale Drug-eluting stent in homogeneous emphysema subjects with severe hyperinflation, the EASE - study. & Local ammendment: Protocol revision to evaluate the ExhaleUltraNeedle in the EASE study.COPDEmphysema10038716NL-OMON30701Broncus Technologies Inc.15
Active, Not Recruiting
N/A
A randomised, double blind study to evaluate the safety and efficacy of the p38 kinase inhibitor, GW856553, in subjects with neuropathic pain from lumbosacral radiculopathyEUCTR2009-012836-33-SEGlaxoSmithKline Research & Development Limited142
Active, Not Recruiting
N/A
A randomised, double blind study to evaluate the safety and efficacy of the p38 kinase inhibitor, GW856553, in subjects with neuropathic pain from lumbosacral radiculopathyeuropathic pain from lumbosacral radiculopathyMedDRA version: 12.0Level: LLTClassification code 10037779Term: RadiculopathyEUCTR2009-012836-33-DEGlaxoSmithKline Research & Development Limited142
Active, Not Recruiting
Phase 1
A randomised, double blind study to evaluate the safety andefficacy of the p38 kinase inhibitor, GW856553, in subjects withneuropathic pain from peripheral nerve injury.Estudio aleatorizado, doble ciego para evaluar la seguridad y la eficacia de GW856553, un inhibidor de la quinasa p38, en sujetos con dolor neuropático por lesión de nervio periférico.europathic painMedDRA version: 9.1Level: LLTClassification code 10054095Term: Neuropathic painEUCTR2009-010091-17-ESGlaxoSmithKline Research & Development Limited